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 Introduction 
 A nerve in the peripheral nervous system is a cord-like struc-
ture that contains many axons. It includes neurons and non-
neuronal Schwann cells that coat the axons in myelin. Myelin 
is an electrically insulating material and forms a sheath around 
the axon, which is fundamental for the proper conduction and 
transmission of electrochemical impulses, by insulating the 
axons from electrically charged atoms and molecules. Complete 
nerve injury (neurotmesis) results in the death of both distal 
axons and Schwann cells with consequent functional loss in 
innervated organs. In contrast to the central nervous system, 
the peripheral nervous system has relevant regenerative capa-
bility, although complete functional recovery is rarely achieved. 
There are a large number of different cell types involved in the 
healing and regeneration of an injured nerve; for example, in 
a peripheral nerve lesion, the axon distal from the injury site 
degenerates, and Schwann cells and later macrophages clean 
the neural tubes of cell debris and myelin, so-called Wallerian 
degeneration.  1 
 When an injury occurs, a gap between the nerve’s dam-
aged ends is produced, and surgical intervention is neces-
sary. Nowadays, there are two main strategies for injuries 
with a long gap. In the fi rst strategy, synthetic or biological 
conduits are sutured to each stump in order to target the distal end, 
avoiding scar tissue infi ltration. A second approach to long gaps 
uses autologous nerve grafts (autografts) to provide a natural 
guidance channel populated with functioning Schwann cells, 
but this is challenging due to donor site collateral effects and 
patient condition.  2 , 3  Because the axon regrows quite slowly 
(about 2–5 mm per day), it is extremely important to accelerate 
the regeneration time or to expand the time window of oppor-
tunity. To reach these goals, current experimental strategies 
include the usage of neurotrophins (proteins that regulate the 
development, maintenance, and function of neurons), growth 
 Magnetic nanoparticles for 
magnetically guided therapies 
against neural diseases 
 G.F.  Goya ,  M.P.  Calatayud ,  B.  Sanz ,  M.  Giannaccini ,  V.  Raffa , 
 T.E.  Torres , and  M.R.  Ibarra 
 Neurological pathologies and nerve damage are two problems of signifi cant medical and 
economic impact because of the hurdles of losing nerve functionality in addition to signifi cant 
mortality and morbidity, and demanding rehabilitation. There are currently a number of 
examples of how nanotechnology can provide new solutions for biomedical problems. 
Current strategies for nerve repair rely on the use of functionalized scaffolds working as 
“nerve guidance channels” to improve axonal regeneration and to direct axonal re-growth 
across the nerve lesion site. Since low invasiveness and high selectivity of the growth 
stimulation are usually confl icting requirements, new approaches are being pursued in order 
to overcome such limitations. Engineered magnetic nanoparticles (MNPs) have emerged from 
this need for noninvasive therapies for both positioning and guiding neural cells in response 
to an external magnetic fi eld. Here, we review the current state of the use of MNPs for 
neuroprotective and magnetically guided therapies. We discuss some conceivable outcomes 
of current magnetically driven strategies seeking integrated platforms for regenerative action 
on damaged tissues. 
 G.F.  Goya ,  Institute of Nanoscience of Aragón ,  Universidad de Zaragoza ,  Spain ;  goya@unizar.es 
 M.P.  Calatayud ,  Institute of Nanoscience of Aragón ,  Universidad de Zaragoza ,  Spain ;  pilarcs@unizar.es 
 B.  Sanz ,  Institute of Nanoscience of Aragón ,  Universidad de Zaragoza ,  Spain ;  beasanz@unizar.es 
 M.  Giannaccini ,  Scuola Superiore Sant’Anna ,  Italy ;  m.giannaccini@sssup.it 
 V.  Raffa ,  Dipartimento di Biologia ,  Università di Pisa ,  Italy ;  vittoria.raffa@unipi.it 
 T.E.  Torres ,  Institute of Nanoscience of Aragón and Laboratory of Advanced Microscopies ,  University of Zaragoza ;  teo@unizar.es 
 M.R.  Ibarra ,  Institute of Nanoscience of Aragón and Laboratory of Advanced Microscopies ,  University of Zaragoza ;  Ibarra@unizar.es 
 DOI: 10.1557/mrs.2014.224 
https://www.cambridge.org/core/terms. https://doi.org/10.1557/mrs.2014.224
Downloaded from https://www.cambridge.org/core. Universidad de Zaragoza, on 22 Jun 2018 at 08:55:36, subject to the Cambridge Core terms of use, available at
 MAGNETIC NANOPARTICLES FOR MAGNETICALLY GUIDED THERAPIES AGAINST NEURAL DISEASES 
966  MRS BULLETIN  •   VOLUME 39  •   NOVEMBER 2014  •   www.mrs.org/bulletin 
factors, neurotransmitters, extracellular matrix proteins, and 
cell therapies mainly based on the use of Schwann cells and 
mesenchymal stem cells.  4  
 In the last decade, we have seen nanoscience gain increas-
ing control over the design, synthesis, and application of 
nanomaterials to nanodevices, starting what we recognize as 
nanotechnology. Nanostructured materials constitute a set of 
potential new therapies for neuroprotective and neuroregener-
ative purposes. These new therapies based on nanotechnology 
will require the ability to fabricate, characterize, and function-
alize a variety of nano-objects adapted to each specifi c need.  5 , 6  
One main purpose of these bio-nanotechnological approaches 
is to transform current scaffold strategies into a more precise 
way to control both physical and biological signals promot-
ing nerve regeneration.  7  Furthermore, as these materials pro-
vide new tools for neural therapies, they inspire new ways 
to improve care for patients with nervous system disorders.  8  
This review provides a general overview of how the magnetic 
properties of magnetic nanoparticles (MNPs) have been recently 
exploited in this fi eld. 
 Magnetic forces 
 The physical basis of remote magnetic actuation requires 
the use of a magnetic “pulling” agent (i.e., magnetic nanopar-
ticles). When placed in a magnetic fi eld  B , the energy of 
a magnetic nanoparticle with magnetic (dipole) moment  m is 
given by  U = − m ∙  B , from which the force on the MNP by 
the fi eld can be extracted:
 ( ).= ∇ ⋅F m B  (1) 
 It follows from  Equation 1 that the force has a maximum value 
along the direction of the fi eld gradient. For decades, there 
have been efforts to use the principle contained in  Equation 1 
to generate magnetic forces capable of moving small (micron- or 
nano-sized, depending on the available technologies at each 
time) magnetic objects. The biological interest in this property 
resulted, for example, in highly effi cient protocols used rou-
tinely for magnetic cell separation. There are many theoretical 
calculations for the minimum values of magnetic forces that 
should be generated in order to manipulate MNPs within the 
cytoplasm. However, these estimations are based on “nude” 
particles and an opsonization process in a biological medium. 
In this process, the particles are coated with different compo-
nents (e.g., albumin, IgG, apolipoproteins) of the biological 
medium, which change their hydrodynamic size, making the 
required forces much larger. 
 There is consensus that magnetic forces in the range of 0.1 
to 1 pN are enough to move MNPs through a moderately dense 
biological medium. Previous reports on magnetic manipulation 
have shown successful actuation in 2D systems using forces 
of 8–16 pN.  9 , 10  Also, recent experiments on magnetically guided 
neural growth have shown that fi eld gradients of 45 T/m are 
enough to obtain positive results for  in vitro neural orien-
tation.  7  Direct physiological effects from magnetic forces 
have also been reported. It has been recently proposed that 
mechanical stress can be produced by magnetic forces on cell 
structures. For example, the production of highly reactive ions 
and “free radicals” involving oxygen molecules, reactive oxygen 
species (ROS), can decrease the cell activity.  11  
 At room temperature, mechanical effects from thermal energy 
on nanometer-sized MNPs are relevant. The thermal energy 
 k B T (where  k B is the Boltzmann constant and  T is the tem-
perature) affects the magnetic behavior of MNPs due to the 
strong dependence of the magnetic relaxation time  τ N (Néel 
relaxation) on the particle’s volume  V through Arrhenius 
exponential decay . For example, a typical 30-nm magnetite 
MNP (i.e., diameter  d = 30 nm,  T = 300 K, effective mag-
netic anisotropy  K eff = 1.1 × 10 
4 J/m 3 ) is expected to display 
a relaxation time  τ N = 2 × 10 
6 s ( ∼ 24 days), and thus for any 
practical purpose, its magnetic moment is blocked. On the 
other side, similar MNPs having  d = 10 nm will relax within 
 τ N = 4.0 × 10 
–10 s, and so for almost any experimental measur-
ing technique, the magnetization will average to zero in the 
absence of an applied magnetic fi eld. In the latter situation, 
it is said that the MNPs are in their superparamagnetic (SPM) 
state. The SPM state of a single domain particle implies null 
values of both the remanence  M R (i.e., magnetization value 
without magnetic fi eld) and the coercive fi eld  H C . 
 MNPs and cell interactions 
 At the cellular level, the interactions between nanomaterials 
and the neural system allowed us to understand many basic 
mechanisms of neural diseases,  12  and in some cases, some new 
ways to repair, replace, or augment the nervous system func-
tion.  13  For any specifi c application in biomedical sciences, the 
selection of MNPs is often determined by the physical proper-
ties of the magnetic material of the core constituting them, as 
well as the chemical/biological characteristics of the functional 
coating. Because they have already been approved for human 
use, iron-oxide NPs have been the most widely employed 
nanomaterial in biomedical studies so far. The magnetic cores 
possess the ability to remotely respond to external magnetic 
fi elds; this capacity has been exploited to manipulate NPs 
under external magnetic forces for targeting purposes, as well 
as for cell separation and labeling, drug delivery, and magnetic 
resonance imaging (MRI).  14  Moreover, the additional property 
of MNPs to absorb energy from time-varying magnetic fi elds 
has been used to induce cell death through heat generation in 
a new protocol known as magnetic hyperthermia.  15  
 Magnetic NPs can be produced by a number of physical 
and chemical methods that determine the fi nal properties of 
the product (see the November 2013 issue of  MRS Bulletin 
on “Magnetic Nanoparticles”). These properties are defi ned by 
the nanoparticle shape and size, the size distribution, and the 
surface chemistry of the resulting particles. The fi nal magnetic 
properties of an ensemble of colloidal MNPs are strongly 
infl uenced by the degree of structural defects or impurities of 
the particle core and surface.  16  Synthesis methods described for 
iron-oxide NPs include co-precipitation, oxidative hydrolysis, 
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microemulsions, and sol-gel reactions.  16 , 17  The effective use of 
MNPs for therapeutic purposes in biomedicine requires the use 
of a colloidal formulation. Because MNPs tend to aggregate 
due to their large surface-to-volume ratio and dipole-dipole 
interactions,  18  colloidal stabilization by surface modifi cation 
is required. Additional key requirements are biocompatibility 
of MNPs and chemical functionality for attachment of specifi c 
ligands or functional groups.  19 , 20  
 MNPs for neural guidance 
 The potential of magnetic materials for a non-invasive 
approach for nerve regeneration is related to the possibility of 
remote actuation of MNPs using an external magnetic fi eld. 
Specifi cally, MNPs can be forced along the direction of the 
external magnetic fi eld to induce projections of the cell body 
(called neurites) along the preferential direction. To improve 
the stability and biocompatibility, these kinds of MNPs can 
be coated with polymers, such as poly-L-lysine (PLL), which 
has been checked for the human neuroblastoma SH-SY5Y cell 
line and primary Schwann cell cultures of the peripheral ner-
vous system,  21  or polyethyleneimine (PEI) that was tested on 
neural models such as PC12 or SH-SY5Y cell lines.  22  
 Transmission electron microscopy (TEM) has been used 
to demonstrate that for these neural cell types, MNPs locate 
in the intracellular fl uid (cytosol) irrespective of the surface 
composition (see  Figure 1 ), but the amount of MNP uptake 
for a given surface composition is characteristic of each neu-
ral cell type. This fact has been exploited in  ex vivo studies 
on olfactory ensheathing cells (OECs) to remotely control the 
migration for regeneration of spinal cord injuries.  23  Multimodal 
iron-oxide NPs have been obtained by conjugation of the NPs 
with Rhodamine-B (MION-Rh) and have been studied  in vitro 
to label mesenchymal stem cells from umbilical cord blood 
(UC-MSC) to evaluate the proliferation kinetics by MRI.  24  
Furthermore, MNPs have been used as a magnetic carrier to 
cross the blood brain barrier (BBB), a protective membrane 
of the neural tissue from toxins, alien substances, and sudden 
changes in blood composition. Indeed, by functionalizing NPs 
with brain-derived neurotrophic factor (BDNF), it has been 
possible to demonstrate the effi cacy and ability of these nano-
vectors to cross the BBB for use as neuroprotectors.  25  
 Impact of iron-oxide MNPs on neural cells and 
the nervous system 
 The eff ects of biological media on iron-oxide MNPs 
 When NPs come in contact with biological fl uids, they adsorb 
proteins and other biomolecules. The formation of NP-protein 
complexes is commonly referred to as the NP-protein corona 
that can critically affect the interaction of NPs with living 
systems.  26  The proteins adsorbed onto NPs depend on many 
variables, including the biological medium and the physico-
chemical characteristics of the NPs (see the Bhattacharya 
et al. article in this issue).  27  
 There is consensus that the protein corona can infl uence 
the uptake of MNPs by cells, as well as their distribution and 
cytotoxicity. Moreover, this protein layer can modify the 
clearance, activity, and toxicity of MNPs through modifi ca-
tions in hydrodynamic size and surface charge.  28  Thus, the 
protein-NP interaction mechanisms must be known in order to 
effi ciently design MNPs that can target specifi c cell types.  29  
 Functionalization of NPs with appropriate polymers that 
provide appropriate functional groups for attachment of spe-
cifi c biological molecules, such as neurotrophic factors or cell 
recognition moieties, is important in the design of NPs for 
biomedical applications.  30 , 31  For instance, it has been recently 
shown that Fe 3 O 4 -based MNPs of similar size but with a 
different surface polymer coating (e.g., polyethyleneimine 
[PEI-MNPs] and poly(acrylic acid)-[PAA-MNPs]) strongly 
infl uence MNPs uptake by SH-SY5Y neuroblastoma cells, a 
tumor cell line of neural crest cell origin and an accepted model 
of neuronal cell behavior. The study concluded that PEI-
MNPs—that adsorbed larger amounts of proteins compared 
to PAA-MNPs—were internalized by the cells 
to a higher extent compared to PAA-MNPs.  28  
 The infl uence of fi nal MNP properties on 
the internalization mechanism and resulting 
intracellular distribution can be studied by 
scanning transmission electron microscopy 
that provides images with  Z -dependent intensity 
contrast ( Z being the atomic number of each 
element) so localization of MNPs within organ-
elles is facilitated. Application of this tech-
nique to the study of internalization pathways 
for different cell types is shown in  Figure 2 
for PEI-MNPs and PAA-MNPs. It can be seen 
that the intracellular distributions are different 
in the two cases due to the different protein 
corona compositions.  26  It is clear that MNP 
surface properties dictate the major biologi-
cal properties and consequently the interac-
tion with a given cell type. Understanding the 
  
 Figure 1.  Typical transmission electron microscope images of (a) PC12 and (b) SH-SY5Y 
cells incubated with polyethyleneimine (PEI)-coated magnetic nanoparticles (MNPs) of 25 nm 
size. The different amounts of MNP uptake are a characteristic of each neural cell type. 
https://www.cambridge.org/core/terms. https://doi.org/10.1557/mrs.2014.224
Downloaded from https://www.cambridge.org/core. Universidad de Zaragoza, on 22 Jun 2018 at 08:55:36, subject to the Cambridge Core terms of use, available at
 MAGNETIC NANOPARTICLES FOR MAGNETICALLY GUIDED THERAPIES AGAINST NEURAL DISEASES 
968  MRS BULLETIN  •   VOLUME 39  •   NOVEMBER 2014  •   www.mrs.org/bulletin 
dynamics of this complex interaction is now recognized as 
the central requisite to better understand the biological impact 
of these novel materials on living organisms. 
 Magnetically assisted neural growth and protection 
 The importance of mechanical factors for the nervous system 
has been appreciated only recently. The idea of tension being 
involved in the morphogenesis of the nervous system arose in 
the late 1970s, when pioneering experimental work revealed 
that neuronal processes of growing neurons  in vitro are under 
tension.  32  Later, it was demonstrated that the external appli-
cation of mechanical tension by glass needles alone is suf-
fi cient to initiate axonal outgrowth (i.e., axonal sprouting and 
lengthening).  33  There is thus some evidence that mechanical 
tension can even induce “stretch growth” of axons, and this 
mechanism can be exploited therapeutically.  34  
 Recently, Fass et al.  35  reported the use of magnetic beads to 
apply a tensile force and study its effect on neurite elongation. 
They were able to identify a force threshold of 15–100 pN. In 
addition to the evidence that mechanical tension can induce 
“stretch growth” of neurites or process initiation, its infl uence 
on axonal re-growth orientation has also been investigated. 
Recently, we reported the use of a MNP-based technique 
for the application of very low tension values (pN or below) 
on neuronal processes.  7  This study demonstrated, using the rat 
pheochromocytoma PC12 cell line, that MNPs can be used to 
manipulate axons/neurites using external magnetic forces for 
controlled directional growth. Altogether, the existing litera-
ture indicates that forces generated by MNPs under static mag-
netic fi elds, when carefully controlled, could act as powerful 
stimulants of neuronal growth and development. 
 Conclusions 
 It is evident that magnetic nanoparticles are just beginning to 
reveal their potential as non-invasive agents for local actuation 
in different neurotherapies. The fi rst steps toward cell targeting 
using specifi c surface molecules have been 
realized, and now “fi ne tuning” of the surface 
chemistry is necessary in order to promote 
axon regeneration. Further progress on materi-
als functionalization is also required for a more 
effi cient targeting of injured neural tissue, a pre-
requisite for any magnetically guided regen-
eration therapy. Although re-myelinating axons 
and removing inhibitory factors are among the 
major problems yet to be solved, there is clear 
advancement on strategies for non-invasive 
guiding of neural cells and axonal regenera-
tion. From a clinical applications perspective, 
much of the  in vitro proofs-of-concept are yet 
to be translated to the  in vivo fi eld in order to 
obtain the fi nal goal (to achieve full neuronal 
regeneration and restoration of lost neuronal 
functions after injury), allowing patients to 
recover both motor and physiological functions. 
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